The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
CTLA4Ig-mediated blockade of T-cell costimulation in patients with psoriasis vulgaris
Open accessAbstract
Engagement of the B7 family of molecules on antigen-presenting cells with their T cell-associated ligands, CD28 and CD152 (cytotoxic T lymphocyte-associated antigen-4 [CTLA-4]), provides a pivotal costimulatory signal in T-cell activation. We investigated the role of the CD28/CD152 pathway in psoriasis in a 26-week, phase I, open-label dose-escalation study. The importance of this pathway in the generation of humoral immune responses to T cell-dependent neoantigens, bacteriophage phiX174 and keyhole limpet hemocyanin, was also evaluated. Forty-three patients with stable psoriasis vulgaris received 4 infusions of the soluble chimeric protein CTLA4Ig (BMS-188667). Forty-six percent of all study patients achieved a 50% or greater sustained improvement in clinical disease activity, with progressively greater effects observed in the highest-dosing cohorts. Improvement in these patients was associated with quantitative reduction in epidermal hyperplasia, which correlated with quantitative reduction in skin-infiltrating T cells. No markedly increased rate of intralesional T-cell apoptosis was identified, suggesting that the decreased number of lesional T cells was probably likely attributable to an inhibition of T-cell proliferation, T-cell recruitment, and/or apoptosis of antigen-specific T cells at extralesional sites. Altered antibody responses to T cell-dependent neoantigens were observed, but immunologic tolerance to these antigens was not demonstrated. This study illustrates the importance of the CD28/CD152 pathway in the pathogenesis of psoriasis and suggests a potential therapeutic use for this novel immunomodulatory approach in an array of T cell-mediated diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation.
Gavrieli, Y., Sherman, Y., & Ben-Sasson, S. A. (1992) · The Journal of cell biology · doi:10.1083/jcb.119.3.493 · Cited by 9,444
Gerdes, J., Lemke, H., Baisch, H., Wacker, H. H., Schwab, U., & Stein, H. (1984) · The Journal of Immunology · doi:10.4049/jimmunol.133.4.1710 · Cited by 4,173
Tivol, E. A., Borriello, F., Schweitzer, A. N., Lynch, W. P., Bluestone, J. A., & Sharpe, A. H. (1995) · Immunity · doi:10.1016/1074-7613(95)90125-6 · Cited by 2,914
CTLA-4 is a second receptor for the B cell activation antigen B7.
Linsley, P. S., Brady, W., Urnes, M., Grosmaire, L. S., Damle, N. K., & Ledbetter, J. A. (1991) · The Journal of experimental medicine · doi:10.1084/jem.174.3.561 · Cited by 1,685
Self-citationMueller, D. L., Jenkins, M. K., & Schwartz, R. H. (1989) · Annual Review of Immunology · doi:10.1146/annurev.iy.07.040189.002305 · Cited by 1,493
CD28 costimulation can promote T cell survival by enhancing the expression of Bcl-xL
Boise, L. H., Minn, A. J., Noel, P. J., June, C. H., Accavitti, M. A., Lindsten, T., & Thompson, C. B. (1995) · Immunity · doi:10.1016/1074-7613(95)90161-2 · Cited by 1,210
Linsley, P. S., Brady, W., Grosmaire, L., Aruffo, A., Damle, N. K., & Ledbetter, J. A. (1991) · The Journal of experimental medicine · doi:10.1084/jem.173.3.721 · Cited by 1,127
Self-citationLong-Term Survival of Xenogeneic Pancreatic Islet Grafts Induced by CTLA4lg
Lenschow, D. J., Zeng, Y., Thistlethwaite, J. R., Montag, A., Brady, W., Gibson, M. G., Linsley, P. S., & Bluestone, J. A. (1992) · Science · doi:10.1126/science.1323143 · Cited by 1,121
Self-citationT Cell Activation Determined by T Cell Receptor Number and Tunable Thresholds
Viola, A., & Lanzavecchia, A. (1996) · Science · doi:10.1126/science.273.5271.104 · Cited by 1,023
Krummel, M. F., & Allison, J. P. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.6.2533 · Cited by 932
CTLA4-Ig and anti-CD40 ligand prevent renal allograft rejection in primates
Kirk, A. D., Harlan, D. M., Armstrong, N. N., Davis, T. A., Dong, Y., Gray, G. S., Hong, X., Thomas, D., Fechner, J. H., & Knechtle, S. J. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.16.8789 · Cited by 929
The Duration of Antigenic Stimulation Determines the Fate of Naive and Effector T Cells
Iezzi, G., Karjalainen, K., & Lanzavecchia, A. (1998) · Immunity · doi:10.1016/s1074-7613(00)80461-6 · Cited by 908
Immunosuppression in Vivo by a Soluble Form of the CTLA-4 T Cell Activation Molecule
Linsley, P. S., Wallace, P. M., Johnson, J., Gibson, M. G., Greene, J. L., Ledbetter, J. A., Singh, C., & Tepper, M. A. (1992) · Science · doi:10.1126/science.1496399 · Cited by 790
Self-citationP- and E-selectin mediate recruitment of T-helper-1 but not T-helper-2 cells into inflamed tissues
Austrup, F., Vestweber, D., Borges, E., Löhning, M., Bräuer, R., Herz, U., Renz, H., Hallmann, R., Scheffold, A., Radbruch, A., et al. (1997) · Nature · doi:10.1038/385081a0 · Cited by 725
Induction of Peripheral T Cell Tolerance In Vivo Requires CTLA-4 Engagement
Perez, V. L., Van Parijs, L., Biuckians, A., Zheng, X. X., Strom, T. B., & Abbas, A. K. (1997) · Immunity · doi:10.1016/s1074-7613(00)80284-8 · Cited by 716
Treatment of Murine Lupus with CTLA4Ig
Finck, B. K., Linsley, P. S., & Wofsy, D. (1994) · Science · doi:10.1126/science.7520604 · Cited by 668
Self-citationGottlieb, S. L., Gilleaudeau, P., Johnson, R., Estes, L., Woodworth, T. G., Gottlieb, A. B., & Krueger, J. G. (1995) · Nature Medicine · doi:10.1038/nm0595-442 · Cited by 606
Self-citationThe Role of T-Cell Costimulatory Activation Pathways in Transplant Rejection
Sayegh, M. H., & Turka, L. A. (1998) · New England Journal of Medicine · doi:10.1056/nejm199806183382506 · Cited by 577
Greaves, M. W., & Weinstein, G. D. (1995) · New England Journal of Medicine · doi:10.1056/nejm199503023320907 · Cited by 512
CD28-B7 blockade after alloantigenic challenge in vivo inhibits Th1 cytokines but spares Th2.
Sayegh, M. H., Akalin, E., Hancock, W. W., Russell, M. E., Carpenter, C. B., Linsley, P. S., & Turka, L. A. (1995) · The Journal of experimental medicine · doi:10.1084/jem.181.5.1869 · Cited by 511
Self-citationLin, H., Bolling, S. F., Linsley, P. S., Wei, R. Q., Gordon, D., Thompson, C. B., & Turka, L. A. (1993) · The Journal of experimental medicine · doi:10.1084/jem.178.5.1801 · Cited by 485
Self-citationConvulsions with an Occult Neural-Crest Tumor
(1979) · New England Journal of Medicine · doi:10.1056/nejm197909063011016 · Cited by 404
Larsen, C. P., Ritchie, S. C., Hendrix, R., Linsley, P. S., Hathcock, K. S., Hodes, R. J., Lowry, R. P., & Pearson, T. C. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.152.11.5208 · Cited by 367
Self-citationThe Roles of Costimulation and Fas in T Cell Apoptosis and Peripheral Tolerance
Van Parijs, L., Ibraghimov, A., & Abbas, A. K. (1996) · Immunity · doi:10.1016/s1074-7613(00)80440-9 · Cited by 351
Nestle, F. O., Turka, L. A., & Nickoloff, B. J. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117308 · Cited by 306
Ozawa, M., Ferenczi, K., Kikuchi, T., Cardinale, I., Austin, L. M., Coven, T. R., Burack, L. H., & Krueger, J. G. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.4.711 · Cited by 298
Self-citationGreene, J. L., Leytze, G. M., Emswiler, J., Peach, R., Bajorath, J., Cosand, W., & Linsley, P. S. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.43.26762 · Cited by 241
Self-citationWebb, L. M. C., Walmsley, M. J., & Feldmann, M. (1996) · European Journal of Immunology · doi:10.1002/eji.1830261008 · Cited by 239
Chang, J. C., Smith, L. R., Froning, K. J., Schwabe, B. J., Laxer, J. A., Caralli, L. L., Kurland, H. H., Karasek, M. A., Wilkinson, D. I., & Carlo, D. J. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.20.9282 · Cited by 232
Bata-Csorgo, Z., Hammerberg, C., Voorhees, J. J., & Cooper, K. D. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117659 · Cited by 225
Immunologic responses to bacteriophage ϕX 174 in immunodeficiency diseases
Ochs, H. D., Davis, S. D., & Wedgwood, R. J. (1971) · Journal of Clinical Investigation · doi:10.1172/jci106756 · Cited by 219
Self-citationCostimulatory B7 Molecules in the Pathogenesis of Infectious and Autoimmune Diseases
Reiser, H., & Stadecker, M. J. (1996) · New England Journal of Medicine · doi:10.1056/nejm199610313351807 · Cited by 214
Tivol, E. A., Boyd, S. D., McKeon, S., Borriello, F., Nickerson, P., Strom, T. B., & Sharpe, A. H. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.11.5091 · Cited by 185
Vallat, V. P., Gilleaudeau, P., Battat, L., Wolfe, J., Nabeya, R., Heftler, N., Hodak, E., Gottlieb, A. B., & Krueger, J. G. (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.1.283 · Cited by 175
Self-citationCross, A. H., Girard, T. J., Giacoletto, K. S., Evans, R. J., Keeling, R. M., Lin, R. F., Trotter, J. L., & Karr, R. W. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117982 · Cited by 162
Mandelbrot, D. A., McAdam, A. J., & Sharpe, A. H. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.2.435 · Cited by 162
Expression and function of B7 on human epidermal Langerhans cells
Symington, F. W., Brady, W., & Linsley, P. S. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.150.4.1286 · Cited by 162
Self-citationExact Inference for Contingency Tables with Ordered Categories
Agresti, A., Mehta, C. R., & Patel, N. R. (1990) · Journal of the American Statistical Association · doi:10.1080/01621459.1990.10476220 · Cited by 151
Regulation of cell surface beta 1 integrin levels during keratinocyte terminal differentiation.
Hotchin, N. A., Gandarillas, A., & Watt, F. M. (1995) · The Journal of Cell Biology · doi:10.1083/jcb.128.6.1209 · Cited by 130
Ronchese, F., Hausmann, B., Hubele, S., & Lane, P. J. L. (1994) · The Journal of Experimental Medicine · doi:10.1084/jem.179.3.809 · Cited by 125
Gottlieb, A. B., Grossman, R., Khandke, L., Carter, D. M., Sehgal, P. B., Fu, S. M., Granelli‐Piperno, A., Rivas, M. V., Barazani, L., & Krueger, J. G. (1992) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12499782 · Cited by 100
Self-citationStrange, P., Cooper, K. D., Hansen, E. R., et al. (1993) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12371678 · Cited by 91
Boise, L., Minn, A. J., Noel, P. J., June, C. H., Accavitti, M. A., Lindsten, T., & Thompson, C. B. (2010) · PubMed · Cited by 83
T-cell receptor V beta expression in normal human skin.
Dunn, D. A., Gadenne, A. S., Simha, S., Lerner, E. A., Bigby, M. E., & Bleicher, P. A. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.4.1267 · Cited by 72
Treatment of Recalcitrant Plaque Psoriasis with a Humanized Non-depleting Antibody to CD4
Bachelez, H., Flageul, B., Dubertret, L., Fraitag, S., Grossman, R., Brousse, N., Poisson, D., Knowles, R. W., Wacholtz, M. C., Haverty, T. P., et al. (1998) · Journal of Autoimmunity · doi:10.1006/jaut.1997.0175 · Cited by 58
Chang, E. Y. (1992) · Archives of Dermatology · doi:10.1001/archderm.1992.01680210057007 · Cited by 57
CD8+ T‐Cells in Psoriatic Lesions Preferentially Use T‐Cell Receptors Vβ3 and/or Vβ13.1 Genes
Chang, J. C. C., Smith, L. R., Froning, K., Schwabe, B. J., Laxer, J. A., Caralli, L. L., Kurland, H. H., Karasek, M. A., Wilkinson, D. I., Carlo, D. J., et al. (1995) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1995.tb44541.x · Cited by 56
Demidem, A., Taylor, J. R., Grammer, S. F., & Streilein, J. W. (1991) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12481465 · Cited by 50
Srinivas, N. R., WEINER, R. S., Warner, G. L., Shyu, W. C., Davidson, T., Fadrowski, C. G., Tay, L. K., Lee, J. S., Greene, D. S., & Barbhaiya, R. H. (1996) · Journal of Pharmaceutical Sciences · doi:10.1021/js950347d · Cited by 17
Self-citation
Cited by
Pathogenesis and therapy of psoriasis
Lowes, M. A., Bowcock, A. M., & Krueger, J. G. (2007) · Nature · doi:10.1038/nature05663 · Cited by 1,778
Self-citationLowes, M. A., Suárez-Fariñas, M., & Krueger, J. G. (2014) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032713-120225 · Cited by 1,650
Self-citationCo-inhibitory molecules of the B7–CD28 family in the control of T-cell immunity
Chen, L. (2004) · Nature Reviews Immunology · doi:10.1038/nri1349 · Cited by 1,257
Davidson, A., & Diamond, B. (2001) · New England Journal of Medicine · doi:10.1056/nejm200108023450506 · Cited by 1,042
Complexities of CD28/B7: CTLA-4 Costimulatory Pathways in Autoimmunity and Transplantation
Salomon, B., & Bluestone, J. A. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.225 · Cited by 1,006
Metadata
- Authors
- Abrams, J. R., Lebwohl, M. G., Guzzo, C. A., Jegasothy, B. V., Goldfarb, M. T., Goffe, B. S., Menter, A., Lowe, N. J., Krueger, G., Brown, M. J., Weiner, R. S., Birkhofer, M. J., Warner, G. L., Berry, K. K., Linsley, P. S., Krueger, J. G., Ochs, H. D., Kelley, S. L., & Kang, S.
- Venue
- Journal of Clinical Investigation
- Published
- 1999-05-01
- Volume
- 103
- Issue
- 9
- Pages
- 1243-1252
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2137096190
- Cited by
- 597
- References
- 49
- FWCI
- 15.27
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.